Abstract
With limited real-world insulin glargine 300 unit/mL (Gla-300) data available, we assessed the effectiveness and safety of Gla-300 in the Japanese type 2 diabetes mellitus (T2DM) population. X-STAR was a prospective, observational, 12-month post-marketing study of Gla-300 from 2015 to 2018. T2DM patients received Gla-300 as the first insulin (insulin-naïve) or after treatment with another type of insulin (insulin-experienced). We identified 1,227 insulin-naïve and 3,394 insulin-experienced patients. Insulin-naïve group increased the Gla-300 starting dose by 2.80 U/day during 12 months (7.49 to 10.29 U/day). Mean HbA1c reduced by 1.99% (9.82 to 7.83%), and 28.4% showed HbA1c < 7.0%. Insulin-experienced group had a baseline insulin dose of 14.86 U/day, which increased by 0.73 U/day. Mean HbA1c reduced by 0.18% (7.99 to 7.81%), and 24.6% showed HbA1c < 7.0%. Adverse drug reactions occurred in 3.42% (insulin-naïve) and 4.45% (insulin-experienced); symptomatic hypoglycemia (2.93% and 3.86%, respectively) was the most common in both groups. Gla-300, in clinical practice, provides an effective and safe therapy as HbA1c was reduced/maintained in insulin-naïve/experienced Japanese T2DM patients without new safety signal. This study prov...Continue Reading
References
Jul 11, 2006·American Heart Journal·Christoph StettlerPeter Diem
Jun 22, 2007·Patient Education and Counseling·Diane WildLinda Gonder-Frederick
May 27, 2008·Lancet·Jianping WengHua Cheng
Oct 17, 2013·Current Medical Research and Opinion·Narihito YoshiokaUNKNOWN DAWN Japan group
Feb 3, 2015·Diabetes, Obesity & Metabolism·G B BolliUNKNOWN on behalf of the EDITION 3 study investigators
May 2, 2015·Diabetes, Obesity & Metabolism·R RitzelH Yki-Järvinen
Jul 15, 2015·Diabetes, Obesity & Metabolism·H Yki-JärvinenM C Riddle
Dec 15, 2015·Diabetes, Obesity & Metabolism·Y TerauchiT Hirose
Oct 12, 2016·Primary Care Diabetes·Kamlesh Khunti, David Millar-Jones
Apr 24, 2017·Diabetes & Metabolism·Y TerauchiUNKNOWN EDITION JP 2 study group
Oct 21, 2017·Diabetes, Obesity & Metabolism·David Russell-JonesKamlesh Khunti
Dec 23, 2017·Diabetes, Obesity & Metabolism·Fang Liz ZhouLawrence Blonde
Apr 10, 2018·Journal of Managed Care & Specialty Pharmacy
Jun 26, 2018·Diabetes, Obesity & Metabolism·Sean D SullivanLawrence Blonde
Aug 15, 2018·Diabetes Care·Julio RosenstockGeremia B Bolli
Sep 19, 2018·PloS One·Jo SatohHiroshi Maegawa
Sep 27, 2018·Journal of the American Psychoanalytic Association·Chris A Heath
Jan 14, 2016·Diabetology International·Shoko TsukubeMasato Odawara
Jan 4, 2019·Diabetology International·Masakazu HanedaEiichi Araki
Dec 21, 2019·Diabetes Care·John B BuseMelanie J Davies